Cystatin C, creatinine, and albuminuria: bringing risk into 3 dimensions
- PMID: 22805517
- PMCID: PMC4136753
- DOI: 10.1053/j.ajkd.2012.05.003
Cystatin C, creatinine, and albuminuria: bringing risk into 3 dimensions
Comment on
-
Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study.Am J Kidney Dis. 2012 Aug;60(2):207-16. doi: 10.1053/j.ajkd.2012.03.011. Epub 2012 Apr 25. Am J Kidney Dis. 2012. PMID: 22537422 Free PMC article.
References
-
- Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145(4):237–246. - PubMed
-
- Menon V, Shlipak MG, Wang X, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med. 2007;147(1):19–27. - PubMed
-
- Tang WHW, Van Lente F, Shrestha K, et al. Impact of myocardial function on cystatin C measurements in chronic systolic heart failure. J Card Fail. 2008;14(5):394–399. - PubMed
-
- Arimoto T, Takeishi Y, Niizeki T, et al. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure. J Card Fail. 2005;11(8):595–601. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
